GIUSTI, ROSA
 Distribuzione geografica
Continente #
EU - Europa 170
NA - Nord America 169
AS - Asia 130
SA - Sud America 18
AF - Africa 4
Totale 491
Nazione #
US - Stati Uniti d'America 156
IT - Italia 115
SG - Singapore 62
HK - Hong Kong 28
CN - Cina 23
BR - Brasile 14
IE - Irlanda 12
SE - Svezia 11
GB - Regno Unito 9
CA - Canada 8
VN - Vietnam 7
FI - Finlandia 6
DE - Germania 5
MX - Messico 5
RU - Federazione Russa 4
AR - Argentina 3
IN - India 3
JP - Giappone 3
BD - Bangladesh 2
BE - Belgio 2
ZA - Sudafrica 2
CL - Cile 1
CZ - Repubblica Ceca 1
FR - Francia 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 491
Città #
Milan 73
Singapore 31
Hong Kong 28
Ashburn 25
Beijing 12
Dublin 12
Princeton 12
Dallas 9
Nyköping 8
Boardman 7
Los Angeles 6
Como 5
Helsinki 5
Houston 5
London 5
Rome 5
Chicago 4
New York 4
São Paulo 4
Chennai 3
Fairfield 3
Ho Chi Minh City 3
Mexico City 3
Montreal 3
San Diego 3
Stockholm 3
Tokyo 3
Toronto 3
Turin 3
Assago 2
Brussels 2
Cambridge 2
Charlotte 2
Denver 2
Frankfurt am Main 2
Genoa 2
Haiphong 2
Massa 2
Ogden 2
Poplar 2
Annapolis 1
Atlanta 1
Augusta 1
Betim 1
Brno 1
Buffalo 1
Calgary 1
Campinas 1
Cape Town 1
Casablanca 1
Charleston 1
Concord 1
Da Nang 1
Dhaka 1
Elk Grove Village 1
Falkenstein 1
Fayetteville 1
Garanhuns 1
Goiatuba 1
Grenoble 1
Guangzhou 1
Hanoi 1
Hounslow 1
Ituzaingó 1
Jackson 1
Jacobina 1
Jaguaruna 1
Johannesburg 1
Juneau 1
Lagos 1
Lomas de Zamora 1
Malnate 1
Maringá 1
Medina 1
Mifflintown 1
Munich 1
Murfreesboro 1
Nova Iguaçu 1
Nuremberg 1
Orem 1
Ottawa 1
Phoenix 1
Querétaro 1
Quilicura 1
Resistencia 1
Rho 1
Santa Clara 1
Santa Fe 1
Seattle 1
Subotica 1
São Luís de Montes Belos 1
São Sebastião do Paraíso 1
Tashkent 1
The Dalles 1
Turku 1
Warsaw 1
Woodbridge 1
Totale 369
Nome #
Surgical repair of postinfarction ventricular septal rupture: current state of the art 72
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 66
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer 61
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG 58
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A multicenter prospective observational study (INVIDIa-2) 55
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy 54
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study 54
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 44
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 39
Totale 503
Categoria #
all - tutte 4.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202225 0 0 0 0 0 0 13 0 0 0 6 6
2022/202339 6 0 0 0 0 12 0 12 0 6 3 0
2023/2024127 4 20 31 28 33 0 0 4 5 1 0 1
2024/2025119 2 1 24 1 7 6 1 15 3 13 12 34
2025/2026193 29 23 13 80 35 13 0 0 0 0 0 0
Totale 503